An act to establish a National Clinical Care Commission
PL 115-80 (S.920), enacted 11/02/2017

131 STAT. 1261 
PUBLIC LAW 115–80—NOV. 2, 2017 
Public Law 115–80 
115th Congress 
An Act 
To establish a National Clinical Care Commission. 
Be it enacted by the Senate and House of Representatives of 
the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘National Clinical Care Commis-
sion Act’’. 
SEC. 2. NATIONAL CLINICAL CARE COMMISSION. 
(a) ESTABLISHMENT.—There is hereby established, within the 
Department of Health and Human Services, a National Clinical 
Care Commission (in this section referred to as the ‘‘Commission’’) 
to evaluate and make recommendations regarding improvements 
to the coordination and leveraging of programs within the Depart-
ment and other Federal agencies related to awareness and clinical 
care for at least one, but not more than two, complex metabolic 
or autoimmune diseases resulting from issues related to insulin 
that represent a significant disease burden in the United States, 
which may include complications due to such diseases. 
(b) MEMBERSHIP.— 
(1) IN GENERAL.—The Commission shall be composed of 
the following voting members: 
(A) The heads of the following Federal agencies and 
departments, or their designees: 
(i) The Centers for Medicare & Medicaid Services. 
(ii) The Agency for Healthcare Research and 
Quality. 
(iii) The Centers for Disease Control and Preven-
tion. 
(iv) The Indian Health Service. 
(v) The Department of Veterans Affairs. 
(vi) The National Institutes of Health. 
(vii) The Food and Drug Administration. 
(viii) The Health Resources and Services Adminis-
tration. 
(ix) The Department of Defense. 
(x) The Department of Agriculture. 
(xi) The Office of Minority Health. 
(B) Twelve additional voting members appointed under 
paragraph (2). 
(2) ADDITIONAL MEMBERS.—The Commission shall include 
additional voting members, as may be appointed by the Sec-
retary, with expertise in the prevention, care, and epidemiology 
of any of the diseases and complications described in subsection 
Evaluation. 
Recommenda- 
tions. 
National Clinical 
Care Commission 
Act. 
Nov. 2, 2017 
[S. 920] 
VerDate Sep 11 2014 
13:12 Jul 14, 2023
Jkt 069194
PO 00000
Frm 00419
Fmt 6580
Sfmt 6581
G:\STATUTES\2017\PT1\RENAMED 32-90\69194PT1.003
69194PT1
jmbennett on LAPBW6H6L3PROD with STATUTES
131 STAT. 1262 
PUBLIC LAW 115–80—NOV. 2, 2017 
(a), including one or more such members from each of the 
following categories: 
(A) 
Physician 
specialties, 
including 
clinical 
endocrinologists, that play a role in the prevention or treat-
ment of diseases and complications described in subsection 
(a). 
(B) Primary care physicians. 
(C) Non-physician health care professionals. 
(D) Patient advocates. 
(E) National experts, including public health experts, 
in the duties listed under subsection (c). 
(F) Health care providers furnishing services to a 
patient population that consists of a high percentage (as 
specified by the Secretary) of individuals who are enrolled 
in a State plan under title XIX of the Social Security 
Act or who are not covered under a health plan or health 
insurance coverage. 
(3) CHAIRPERSON.—The members of the Commission shall 
select a chairperson from the members appointed under para-
graph (2). 
(4) MEETINGS.—The Commission shall meet at least twice, 
and not more than four times, a year. 
(5) VACANCIES.—A vacancy on the Commission shall be 
filled in the same manner as the original appointments. 
(c) DUTIES.—The Commission shall evaluate and make rec-
ommendations, as appropriate, to the Secretary of Health and 
Human Services and Congress regarding— 
(1) Federal programs of the Department of Health and 
Human Services that focus on preventing and reducing the 
incidence of the diseases and complications described in sub-
section (a); 
(2) current activities and gaps in Federal efforts to support 
clinicians in providing integrated, high-quality care to individ-
uals with the diseases and complications described in subsection 
(a); 
(3) the improvement in, and improved coordination of, Fed-
eral education and awareness activities related to the preven-
tion and treatment of the diseases and complications described 
in subsection (a), which may include the utilization of new 
and existing technologies; 
(4) methods for outreach and dissemination of education 
and awareness materials that— 
(A) address the diseases and complications described 
in subsection (a); 
(B) are funded by the Federal Government; and 
(C) are intended for health care professionals and the 
public; and 
(5) whether there are opportunities for consolidation of 
inappropriately overlapping or duplicative Federal programs 
related to the diseases and complications described in sub-
section (a). 
(d) OPERATING PLAN.—Not later than 90 days after its first 
meeting, the Commission shall submit to the Secretary of Health 
and Human Services and the Congress an operating plan for car-
rying out the activities of the Commission as described in subsection 
(c). Such operating plan may include— 
Lists. 
Deadline. 
VerDate Sep 11 2014 
13:12 Jul 14, 2023
Jkt 069194
PO 00000
Frm 00420
Fmt 6580
Sfmt 6581
G:\STATUTES\2017\PT1\RENAMED 32-90\69194PT1.003
69194PT1
jmbennett on LAPBW6H6L3PROD with STATUTES
131 STAT. 1263 
PUBLIC LAW 115–80—NOV. 2, 2017 
LEGISLATIVE HISTORY—S. 920: 
CONGRESSIONAL RECORD, Vol. 163 (2017): 
Sept. 6, considered and passed Senate. 
Oct. 11, considered and passed House. 
(1) a list of specific activities that the Commission plans 
to conduct for purposes of carrying out the duties described 
in each of the paragraphs in subsection (c); 
(2) a plan for completing the activities; 
(3) a list of members of the Commission and other individ-
uals who are not members of the Commission who will need 
to be involved to conduct such activities; 
(4) an explanation of Federal agency involvement and 
coordination needed to conduct such activities; 
(5) a budget for conducting such activities; and 
(6) other information that the Commission deems appro-
priate. 
(e) FINAL REPORT.—By not later than 3 years after the date 
of the Commission’s first meeting, the Commission shall submit 
to the Secretary of Health and Human Services and the Congress 
a final report containing all of the findings and recommendations 
required by this section. 
(f) SUNSET.—The Commission shall terminate 60 days after 
submitting its final report, but not later than the end of fiscal 
year 2021. 
Approved November 2, 2017. 
Budget. 
VerDate Sep 11 2014 
13:12 Jul 14, 2023
Jkt 069194
PO 00000
Frm 00421
Fmt 6580
Sfmt 6580
G:\STATUTES\2017\PT1\RENAMED 32-90\69194PT1.003
69194PT1
jmbennett on LAPBW6H6L3PROD with STATUTES